SV Life Sciences Fund IV (GP), L.P., 10% Owner at NeurogesX Inc (NGSX), sold 300,000 shares at $10.25 ($3.1M) on 2010-05-03, disclosed to the SEC on 2010-05-05.
Open-market sale of $3.1M NGSX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.25 | 8,282 | $85K | 2.8% |
| 2 | $10.25 | 291,718 | $3.0M | 97.2% |
| Total | $10.25 avg | 300,000 | $3.1M | 100% |
| Filing → |
| OPHT | SELL | 2014-05-29 | $26.3M | — | Filing → |